rs1057517193
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_152618.3(BBS12):c.1082delG(p.Gly361ValfsTer22) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_152618.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS12 | NM_152618.3 | c.1082delG | p.Gly361ValfsTer22 | frameshift_variant | Exon 2 of 2 | ENST00000314218.8 | NP_689831.2 | |
BBS12 | NM_001178007.2 | c.1082delG | p.Gly361ValfsTer22 | frameshift_variant | Exon 3 of 3 | NP_001171478.1 | ||
BBS12 | XM_011531680.3 | c.1082delG | p.Gly361ValfsTer22 | frameshift_variant | Exon 2 of 2 | XP_011529982.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BBS12 | ENST00000314218.8 | c.1082delG | p.Gly361ValfsTer22 | frameshift_variant | Exon 2 of 2 | 1 | NM_152618.3 | ENSP00000319062.3 | ||
BBS12 | ENST00000542236.5 | c.1082delG | p.Gly361ValfsTer22 | frameshift_variant | Exon 3 of 3 | 2 | ENSP00000438273.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251364Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135874
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727230
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74376
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 12 Pathogenic:3
- -
- -
- -
Bardet-Biedl syndrome Pathogenic:2
This sequence change creates a premature translational stop signal (p.Gly361Valfs*22) in the BBS12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 350 amino acid(s) of the BBS12 protein. This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Bardet-Biedl syndrome (PMID: 24611592). ClinVar contains an entry for this variant (Variation ID: 371339). This variant disrupts a region of the BBS12 protein in which other variant(s) (p.Arg675*) have been determined to be pathogenic (PMID: 20827784, 21642631). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Variant summary: BBS12 c.1082delG (p.Gly361ValfsX22) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Downstream variants have been reported as pathogenic by our lab. The variant allele was found at a frequency of 4e-06 in 251364 control chromosomes. c.1082delG has been reported in the literature in individuals affected with Bardet-Biedl Syndrome (example: Alvarez-Satta_2014). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 371339). Based on the evidence outlined above, the variant was classified as pathogenic. -
BBS12-related disorder Pathogenic:1
The BBS12 c.1082delG variant is predicted to result in a frameshift and premature protein termination (p.Gly361Valfs*22). This variant has been reported to be causative for Bardet-Biedl syndrome (Alvarez-Satta et al. 2014. PubMed ID: 24611592). This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in BBS12 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at